Cameron Gofton

538 total citations · 1 hit paper
9 papers, 303 citations indexed

About

Cameron Gofton is a scholar working on Epidemiology, Hepatology and Pathology and Forensic Medicine. According to data from OpenAlex, Cameron Gofton has authored 9 papers receiving a total of 303 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 4 papers in Hepatology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Cameron Gofton's work include Liver Disease Diagnosis and Treatment (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and Hepatitis C virus research (2 papers). Cameron Gofton is often cited by papers focused on Liver Disease Diagnosis and Treatment (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and Hepatitis C virus research (2 papers). Cameron Gofton collaborates with scholars based in Australia, Italy and China. Cameron Gofton's co-authors include Jacob George, Ming‐Hua Zheng, Jacob George, Harry Crane, Ankur Sharma, Simone I. Strasser, Meera Agar, Mi Na Kim, Gianluca Svegliati‐Baroni and Beom Kyung Kim and has published in prestigious journals such as SHILAP Revista de lepidopterología, Seminars in Liver Disease and Journal of Gastroenterology.

In The Last Decade

Cameron Gofton

6 papers receiving 298 citations

Hit Papers

MAFLD: How is it different from NAFLD? 2022 2026 2023 2024 2022 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cameron Gofton Australia 5 238 122 77 51 43 9 303
Jacob George Australia 5 246 1.0× 116 1.0× 95 1.2× 44 0.9× 46 1.1× 17 322
Valentina Peta France 8 206 0.9× 77 0.6× 75 1.0× 32 0.6× 48 1.1× 16 245
Margaret LP Teng Singapore 2 292 1.2× 132 1.1× 98 1.3× 76 1.5× 56 1.3× 2 359
CP Day United Kingdom 4 171 0.7× 66 0.5× 66 0.9× 51 1.0× 41 1.0× 11 241
Heejoon Jang South Korea 9 204 0.9× 107 0.9× 116 1.5× 26 0.5× 42 1.0× 17 283
Federica Spatola Italy 8 245 1.0× 120 1.0× 109 1.4× 28 0.5× 18 0.4× 20 287
Yanlan Fang China 6 271 1.1× 159 1.3× 50 0.6× 96 1.9× 61 1.4× 23 390
Dennis Schrijnders Netherlands 6 136 0.6× 63 0.5× 69 0.9× 52 1.0× 22 0.5× 10 242
Lampros Chrysavgis Greece 10 258 1.1× 115 0.9× 88 1.1× 96 1.9× 91 2.1× 18 396
KeeSeok Lee United States 5 183 0.8× 78 0.6× 81 1.1× 22 0.4× 38 0.9× 14 228

Countries citing papers authored by Cameron Gofton

Since Specialization
Citations

This map shows the geographic impact of Cameron Gofton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cameron Gofton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cameron Gofton more than expected).

Fields of papers citing papers by Cameron Gofton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cameron Gofton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cameron Gofton. The network helps show where Cameron Gofton may publish in the future.

Co-authorship network of co-authors of Cameron Gofton

This figure shows the co-authorship network connecting the top 25 collaborators of Cameron Gofton. A scholar is included among the top collaborators of Cameron Gofton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cameron Gofton. Cameron Gofton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Gofton, Cameron & Jacob George. (2025). Non-Invasive Testing in Metabolic Dysfunction Associated Fatty Liver Disease. Archives of Medical Research. 56(8). 103337–103337.
2.
Gofton, Cameron & George Casella. (2024). Dawn of an era of effective treatments for MAFLD. SHILAP Revista de lepidopterología. 3(4). 206–216.
3.
Crane, Harry, Guy D. Eslick, Cameron Gofton, et al.. (2024). Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis. Clinical and Molecular Hepatology. 30(3). 436–448. 25 indexed citations
4.
Read, Scott, Asma Baig, Kate Marshall, et al.. (2024). Efficacy of albumin use in decompensated cirrhosis and real‐world adoption in Australia. JGH Open. 8(9). e70029–e70029.
5.
Gofton, Cameron, et al.. (2024). Micro‐elimination of chronic hepatitis C virus in mental health settings: A prospective multicentre pragmatic trial. Drug and Alcohol Review. 43(5). 1247–1255. 2 indexed citations
6.
Crane, Harry, Cameron Gofton, Ankur Sharma, & Jacob George. (2023). MAFLD: an optimal framework for understanding liver cancer phenotypes. Journal of Gastroenterology. 58(10). 947–964. 27 indexed citations
7.
Gofton, Cameron, et al.. (2022). MAFLD: How is it different from NAFLD?. Clinical and Molecular Hepatology. 29(Suppl). S17–S31. 238 indexed citations breakdown →
8.
Gofton, Cameron, Meera Agar, & Jacob George. (2022). Early Implementation of Palliative and Supportive Care in Hepatocellular Carcinoma. Seminars in Liver Disease. 42(4). 514–530. 5 indexed citations
9.
Gofton, Cameron & Jacob George. (2021). Updates in fatty liver disease: Pathophysiology, diagnosis and management. Australian Journal of General Practice. 50(10). 702–707. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026